Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Exercise/Conversion of 25,000 ORKA shares, $195.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 25,000 | $195.0K |
| Sep 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 2,452 | $234.7K |
| Sep 1, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 75,000 | $585.0K |
| Jun 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 1,729 | $120.5K |
| Jun 11, 2026 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 34,843 | n/a |
| Mar 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 1,729 | $71.4K |
| Jan 23, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 76,700 | n/a |
| May 1, 2025 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 23,017 | n/a |
| Jan 24, 2025 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 230,000 | n/a |
| Jun 8, 2023 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 47,000 | n/a |